Sinphar Pharmaceutical (Taiwan) Probability of Future Stock Price Finishing Over 30.92
| 1734 Stock | TWD 31.25 0.10 0.32% |
Sinphar |
Sinphar Pharmaceutical Target Price Odds to finish over 30.92
The tendency of Sinphar Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above NT$ 30.92 in 90 days |
| 31.25 | 90 days | 30.92 | about 75.66 |
Based on a normal probability distribution, the odds of Sinphar Pharmaceutical to stay above NT$ 30.92 in 90 days from now is about 75.66 (This Sinphar Pharmaceutical Co probability density function shows the probability of Sinphar Stock to fall within a particular range of prices over 90 days) . Probability of Sinphar Pharmaceutical price to stay between NT$ 30.92 and its current price of NT$31.25 at the end of the 90-day period is about 6.31 .
Assuming the 90 days trading horizon Sinphar Pharmaceutical Co has a beta of -0.39. This suggests as returns on the benchmark increase, returns on holding Sinphar Pharmaceutical are expected to decrease at a much lower rate. During a bear market, however, Sinphar Pharmaceutical Co is likely to outperform the market. Additionally Sinphar Pharmaceutical Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Sinphar Pharmaceutical Price Density |
| Price |
Predictive Modules for Sinphar Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sinphar Pharmaceutical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sinphar Pharmaceutical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Sinphar Pharmaceutical is not an exception. The market had few large corrections towards the Sinphar Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Sinphar Pharmaceutical Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Sinphar Pharmaceutical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.2 | |
β | Beta against Dow Jones | -0.39 | |
σ | Overall volatility | 1.74 | |
Ir | Information ratio | -0.19 |
Sinphar Pharmaceutical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sinphar Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sinphar Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Sinphar Pharmaceutical generated a negative expected return over the last 90 days | |
| The company reported the revenue of 2.43 B. Net Loss for the year was (38.13 M) with profit before overhead, payroll, taxes, and interest of 888.71 M. | |
| About 20.0% of the company shares are owned by insiders or employees |
Sinphar Pharmaceutical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Sinphar Stock often depends not only on the future outlook of the current and potential Sinphar Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sinphar Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 167.7 M |
Sinphar Pharmaceutical Technical Analysis
Sinphar Pharmaceutical's future price can be derived by breaking down and analyzing its technical indicators over time. Sinphar Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sinphar Pharmaceutical Co. In general, you should focus on analyzing Sinphar Stock price patterns and their correlations with different microeconomic environments and drivers.
Sinphar Pharmaceutical Predictive Forecast Models
Sinphar Pharmaceutical's time-series forecasting models is one of many Sinphar Pharmaceutical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Sinphar Pharmaceutical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Sinphar Pharmaceutical
Checking the ongoing alerts about Sinphar Pharmaceutical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Sinphar Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Sinphar Pharmaceutical generated a negative expected return over the last 90 days | |
| The company reported the revenue of 2.43 B. Net Loss for the year was (38.13 M) with profit before overhead, payroll, taxes, and interest of 888.71 M. | |
| About 20.0% of the company shares are owned by insiders or employees |
Additional Tools for Sinphar Stock Analysis
When running Sinphar Pharmaceutical's price analysis, check to measure Sinphar Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinphar Pharmaceutical is operating at the current time. Most of Sinphar Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sinphar Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinphar Pharmaceutical's price. Additionally, you may evaluate how the addition of Sinphar Pharmaceutical to your portfolios can decrease your overall portfolio volatility.